Ricevi le ultime notizie sulle azioni Anebulo Pharmaceuticals con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di ANEB

Ultime notizie per

ANEBULO PHARMACEUTICALS INC

Anebulo Pharmaceuticals

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals Inc

Press Releases

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates

Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock

Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives

Penny Stocks

Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity

Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates

ANEB

Assertio Holdings

Biote

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Context Therapeutics

Cardiol Therapeutics Inc. - Class A Common Shares

Cardiol Therapeutics

Cybin

Journey Medical Corporation - Common Stock

Journey Medical

Hyperion DeFi

ImageneBio

Intercure

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals

NRX Pharmaceuticals

Nasus Pharma

Nutriband

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Pliant Therapeutics

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares

Quantum BioPharma

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Cassava Sciences

Scilex Holding

Sol-Gel Technologies Ltd. - Ordinary Shares

Sol-Gel Technologies

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Veru

Zhengye Biotechnology Holding Limited - Ordinary Shares

Comments

Anebulo Pharmaceuticals Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO